Clinical trials on skin have demonstrated improvements: In one study, GHK-Cu applied to photoaged skin for 12 weeks increased density and thickness while reducing laxity and wrinkles in 71 women
There is insufficient clinical research to establish the safety or efficacy of these injections in pregnant women, so avoiding them is advised to prevent any possible risk to the developing fetus
Experimental models have examined its influence on vascular endothelial growth factor receptor-2 (VEGFR2) signaling, including activation of downstream VEGFR2AkteNOS pathways associated with endothelial cell proliferation and vascular signaling processes
SLU-PP-332 has been shown to reduce fat mass, improve insulin sensitivity, and significantly enhance exercise endurance
You might think you're administering a 1mg dose, but in reality, you're administering a fraction of that, along with a cocktail of unknown degradants